日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/07 | 5,880 | 5,940 | 5,840 | 5,870 | -70 | -1.2% | 457,100 |
| 2023/03/06 | 5,990 | 6,000 | 5,890 | 5,940 | -20 | -0.3% | 318,800 |
| 2023/03/03 | 5,890 | 6,000 | 5,870 | 5,960 | +70 | +1.2% | 428,700 |
| 2023/03/02 | 5,810 | 5,960 | 5,810 | 5,890 | -10 | -0.2% | 395,300 |
| 2023/03/01 | 6,010 | 6,050 | 5,900 | 5,900 | -200 | -3.3% | 413,400 |
| 2023/02/28 | 6,110 | 6,180 | 6,040 | 6,100 | +20 | +0.3% | 493,800 |
| 2023/02/27 | 6,060 | 6,080 | 6,010 | 6,080 | -30 | -0.5% | 415,100 |
| 2023/02/24 | 6,180 | 6,180 | 6,100 | 6,110 | -160 | -2.6% | 439,000 |
| 2023/02/22 | 6,300 | 6,390 | 6,260 | 6,270 | -40 | -0.6% | 291,400 |
| 2023/02/21 | 6,340 | 6,360 | 6,270 | 6,310 | ±0 | ±0% | 155,400 |
| 2023/02/20 | 6,320 | 6,390 | 6,260 | 6,310 | +50 | +0.8% | 328,800 |
| 2023/02/17 | 6,270 | 6,290 | 6,190 | 6,260 | -50 | -0.8% | 432,200 |
| 2023/02/16 | 6,430 | 6,450 | 6,300 | 6,310 | -120 | -1.9% | 342,700 |
| 2023/02/15 | 6,550 | 6,550 | 6,410 | 6,430 | -130 | -2% | 237,700 |
| 2023/02/14 | 6,580 | 6,590 | 6,510 | 6,560 | +80 | +1.2% | 185,700 |
| 2023/02/13 | 6,630 | 6,680 | 6,460 | 6,480 | -150 | -2.3% | 309,400 |
| 2023/02/10 | 6,600 | 6,630 | 6,570 | 6,630 | -30 | -0.5% | 201,200 |
| 2023/02/09 | 6,650 | 6,670 | 6,620 | 6,660 | -40 | -0.6% | 134,600 |
| 2023/02/08 | 6,670 | 6,730 | 6,630 | 6,700 | +110 | +1.7% | 236,900 |
| 2023/02/07 | 6,640 | 6,660 | 6,590 | 6,590 | -50 | -0.8% | 148,100 |
| 2023/02/06 | 6,640 | 6,680 | 6,600 | 6,640 | +50 | +0.8% | 158,900 |
| 2023/02/03 | 6,630 | 6,650 | 6,560 | 6,590 | -110 | -1.6% | 217,100 |
| 2023/02/02 | 6,740 | 6,740 | 6,660 | 6,700 | ±0 | ±0% | 194,400 |
| 2023/02/01 | 6,710 | 6,750 | 6,680 | 6,700 | +30 | +0.4% | 197,100 |
| 2023/01/31 | 6,700 | 6,730 | 6,670 | 6,670 | -50 | -0.7% | 160,300 |
| 2023/01/30 | 6,720 | 6,790 | 6,700 | 6,720 | +40 | +0.6% | 307,600 |
| 2023/01/27 | 6,700 | 6,740 | 6,670 | 6,680 | -50 | -0.7% | 177,200 |
| 2023/01/26 | 6,760 | 6,780 | 6,700 | 6,730 | -30 | -0.4% | 201,700 |
| 2023/01/25 | 6,740 | 6,760 | 6,680 | 6,760 | +20 | +0.3% | 251,100 |
| 2023/01/24 | 6,780 | 6,790 | 6,680 | 6,740 | +20 | +0.3% | 372,800 |
| 2023/01/23 | 6,710 | 6,810 | 6,710 | 6,720 | +30 | +0.4% | 273,300 |
| 2023/01/20 | 6,740 | 6,770 | 6,670 | 6,690 | -90 | -1.3% | 277,200 |
| 2023/01/19 | 6,810 | 6,900 | 6,730 | 6,780 | -70 | -1% | 218,600 |
| 2023/01/18 | 6,740 | 6,880 | 6,720 | 6,850 | +190 | +2.9% | 199,100 |
| 2023/01/17 | 6,730 | 6,740 | 6,650 | 6,660 | -90 | -1.3% | 236,000 |
| 2023/01/16 | 6,720 | 6,810 | 6,720 | 6,750 | -30 | -0.4% | 154,200 |
| 2023/01/13 | 6,860 | 6,960 | 6,750 | 6,780 | -180 | -2.6% | 320,500 |
| 2023/01/12 | 7,100 | 7,110 | 6,950 | 6,960 | -110 | -1.6% | 196,100 |
| 2023/01/11 | 6,990 | 7,100 | 6,980 | 7,070 | +40 | +0.6% | 221,700 |
| 2023/01/10 | 7,120 | 7,200 | 7,030 | 7,030 | -40 | -0.6% | 198,500 |
| 2023/01/06 | 7,140 | 7,170 | 7,060 | 7,070 | +10 | +0.1% | 213,900 |
| 2023/01/05 | 7,080 | 7,110 | 6,970 | 7,060 | -100 | -1.4% | 334,700 |
| 2023/01/04 | 7,330 | 7,330 | 7,160 | 7,160 | -320 | -4.3% | 164,300 |
| 2022/12/30 | 7,560 | 7,600 | 7,440 | 7,480 | -40 | -0.5% | 149,900 |
| 2022/12/29 | 7,410 | 7,530 | 7,370 | 7,520 | +80 | +1.1% | 99,400 |
| 2022/12/28 | 7,400 | 7,460 | 7,340 | 7,440 | -50 | -0.7% | 179,200 |
| 2022/12/27 | 7,540 | 7,570 | 7,430 | 7,490 | +20 | +0.3% | 158,400 |
| 2022/12/26 | 7,540 | 7,540 | 7,400 | 7,470 | -80 | -1.1% | 100,900 |
| 2022/12/23 | 7,480 | 7,550 | 7,450 | 7,550 | +30 | +0.4% | 98,000 |
| 2022/12/22 | 7,530 | 7,550 | 7,460 | 7,520 | +30 | +0.4% | 167,400 |
551～
600
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +8.0% | -15.3% | 3.54% | 9.84倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 333,800円 | +3.8% | -19.9% | 4.07% | 10.92倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 352,000円 | - | - | 0.00% | - | 163.04倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 169,500円 | +5.0% | +1.5% | 0.00% | 14.50倍 | 3.86倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ジーエヌアイ | 420,000円 | +21.7% | +999.9% | 0.00% | 17.59倍 | 5.82倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
